当前位置：易推广 > 上海陶术生物科技有限公司 > 产品展示
企业档案
会员类型：会员
已获得易推广信誉 等级评定
(0 -40)基础信誉积累，可浏览访问
(41-90)良好信誉积累，可接洽商谈
(91+ )优质信誉积累，可持续信赖
易推广会员：5年
工商认证 【已认证】
最后认证时间：
注册号： 【已认证】
法人代表： 【已认证】
企业类型：生产商 【已认证】
注册资金：人民币万 【已认证】
产品数：86101
参观次数：3536270
自主品牌
已选条件
-
TP1957LPKI (5-24) Acetate(99534-03-9 free base)PKI (524) Acetate(99534039 free base),PKI (5 24) Acetate(995
PKI (5-24) Acetate is a high affinity PKA inhibitor (Ki = 2.3 nM).
价 格：￥电议型 号：TP1957L产 地：中国大陆
-
T12347p38-α MAPK-IN-1Inhibitor,inhibit,p-38-α MAPK-IN-1,Autophagy,p38α MAPKIN1,p38 MAPK,p38 α MAPK IN 1
p38-α MAPK-IN-1 is a MAPK14 (p38-α) inhibitor with IC50 of 2300 nM and 5500 nM in EFC displacement assay and HTRF assay,respectively.
价 格：￥电议型 号：T12347产 地：中国大陆
-
T21983LPKI 14-22 amide, myristoylated AcetatePKI 14-22 amide, myristoylated Acetate(201422-03-9 Free base)
PKI 14-22 amide, myristoylated Acetate inhibit cAMP-dependent protein kinase (PKA) and blocks hyperalgesia produced by spinal administration of 8-bromo-cAMP.?
价 格：￥电议型 号：T21983L产 地：中国大陆
-
T1970GedatolisibPKI-587；PF-05212384
Gedatolisib is a highly effective dual inhibitor targeting the PI3Kα/γ (IC50: 0.4/5.4 nM)and mTOR (IC50: 1.6 nM) in the PI3K/mTOR signaling pathway.
价 格：￥电议型 号：T1970产 地：中国大陆
-
-
T1970GedatolisibGedatolisib,PF-05212384,PKI-587
Gedatolisib is a highly effective dual inhibitor targeting the PI3Kα/γ (IC50: 0.4/5.4 nM)and mTOR (IC50: 1.6 nM) in the PI3K/mTOR signaling pathway.
价 格：￥电议型 号：T1970产 地：美洲
-
T6154SU11274SU11274,PKI-SU11274,Met Kinase Inhibitor
SU11274(IC50=10 nM) is a specific Met inhibitor. It shows no significant effects on PGDFRβ, EGFR or Tie2.
价 格：￥电议型 号：T6154产 地：美洲
-
T81447PKItide；化合物 PKItidePKItide
PKItide demonstrates an inhibitory concentration 50 (IC50) of 0.2 μM against cAMP-dependent protein kinase (cAMP-PK) [1].
价 格：￥电议型 号：T81447产 地：中国大陆
-
T76482PKI (5-24),amide；化合物 PKI (5-24),amidePKI (5-24),amide
PKI (5-24),amide (IP20-amide) is a potent inhibitor of cAMP-dependent protein kinase (PKA) (PKA), with an inhibition constant (K i ) of 2.3 nM [1]. This 20-residue peptide mirrors the active segment of the heat-stable inhibitor protein specific to PKA, showcasing its significant inhibitory efficacy.
价 格：￥电议型 号：T76482产 地：中国大陆
-
T76481LPKI (14-24)amide TFA；化合物 PKI (14-24)amide TFAPKI (14-24)amide TFA
PKI (14-24)amide TFA, a potent inhibitor of Protein Kinase A (PKA), significantly reduces cyclic AMP-dependent protein kinase activity within cellular homogenates, as evidenced by research findings [1] [2].
价 格：￥电议型 号：T76481L产 地：中国大陆
-
T76481PKI (14-24)amide；化合物 PKI (14-24)amidePKI (14-24)amide
PKI (14-24)amide is a potent inhibitor of Protein Kinase A (PKA), demonstrating strong inhibition of cyclic AMP-dependent protein kinase activity in cell homogenates [1] [2].
价 格：￥电议型 号：T76481产 地：中国大陆
-
T76399PKI(5-22)amide；化合物 PKI(5-22)amidePKI(5-22)amide
PKI(5-22)amide, an active inhibitory fragment of the cyclic AMP-dependent protein kinase (PKA) inhibitor, effectively prevents PKA activation. However, it does not reduce the homologous desensitization of CRF1 receptors [1] [2].
价 格：￥电议型 号：T76399产 地：中国大陆
-
T75889PKI 14-22 amide,myristoylated TFA；化合物 PKI 14-22 amide,myristoylated TFAPKI 14-22 amide,myristoylated
PKI 14-22 amide, myristoylated TFA is a potent inhibitor of cAMP-dependent protein kinase A (PKA) that diminishes IgG-mediated phagocytic response and inhibits neutrophil adhesion [1].
价 格：￥电议型 号：T75889产 地：中国大陆
-
T75888PKA Inhibitor Fragment (6-22) amide TFA；PKA Inhibitor Fragment (6-22) amide三氟乙酸盐PKI-(6-22)-amide TFA
PKA Inhibitor Fragment (6-22) amide TFA (PKA Inhibitor Fragment (6-22) amide TFA) is an inhibitor of the highly potent cAMP-dependent protein kinase A (PKA) inhibitor (Ki: 2.8 nM).PKA Inhibitor Fragment (6-22) amide TFA reverses the pain-relieving effects of low levels of morphine in mice.
价 格：￥电议型 号：T75888产 地：中国大陆
-
T75739PKI(5-24) TFA；化合物 PKI(5-24) TFAPKI(5-24) TFA
PKI(5-24) TFA is a synthetic peptide inhibitor of PKA (cAMP-dependent protein kinase), characterized by its potent and competitive inhibition properties, exhibiting a K i of 2.3 nM. It corresponds to residues 5-24 found in the natural heat-stable protein kinase inhibitor [1] [2].
价 格：￥电议型 号：T75739产 地：中国大陆
-
T6154SU11274；化合物SU11274Met Kinase Inhibitor|||PKI-SU11274；Met Kinase Inhibitor|||PKI-SU11274
SU11274 (Met Kinase Inhibitor)(IC50=10 nM) is a specific Met inhibitor. It shows no significant effects on PGDFRβ, EGFR or Tie2.
价 格：￥电议型 号：T6154产 地：中国大陆
-
T36643PKI-166 hydrochloridePKI 166 hydrochloridePKI166 hydrochloride|||PKI 166 hydrochloride
Potent EGFR-kinase inhibitor (IC50 = 0.7 nM). Displays >3000-fold selectivity against a panel of serine/threonine kinases. Reduces metastasis and angiogenesis in a mouse model of pancreatic cancer. Antihypertensive and orally bioavailable.
价 格：￥电议型 号：T36643产 地：中国大陆
-
T3656PKI-402；化合物PKI-402PKI-402
PKI-402 is a potent PI3K and mTOR inhibitor. PKI-402 inhibits PI3Kα, mTOR, PI3Kβ, PI3Kδ and PI3Kγ with IC50s of 2, 3, 7, 14 and 16 nM, respectively.
价 格：￥电议型 号：T3656产 地：中国大陆
-
T36085PKI-179 hydrochloride；PKI-179 (hydrochloride)PKI-179 hydrochloride
PKI-179 is an orally bioavailable dual inhibitor of PI3K and mammalian target of rapamycin (mTOR). In an in vitro enzymatic assay, it potently inhibits PI3K (IC50s = 8, 24, 17, and 74 nM for isoforms α, β, δ, and γ, respectively), two common PI3Kα mutants, E545K and H1047R (IC50s = 14 and 11 nM, respectively), and mTOR (IC50 = 0.42 nM). PKI-179 is selective for PI3K and mTOR over a panel of 361 other kinases at IC50 values up to 50 μM, hERG (IC50 > 30 μM), and cytochrome P450 (CYP) isoforms (IC5
价 格：￥电议型 号：T36085产 地：中国大陆
-
T36084PKI-179；PKI-179PKI-179
PKI-179 is a potent, orally active compound that functions as a dual PI3K/mTOR inhibitor. It demonstrates IC50 values of 8 nM for PI3K-α, 24 nM for PI3K-β, 74 nM for PI3K-γ, 77 nM for PI3K-δ, and 0.42 nM for mTOR. Additionally, it is effective against E545K and H1047R mutations, with IC50s of 14 nM and 11 nM, respectively. In vivo studies have shown that PKI-179 possesses anti-tumor capabilities[1][2].
价 格：￥电议型 号：T36084产 地：中国大陆
